Your session is about to expire
← Back to Search
Trazodone for Obstructive Sleep Apnea
Study Summary
This trial aims to test if giving trazodone before sleep can help improve symptoms and severity of obstructive sleep apnea by allowing the upper airway muscles to work effectively during sleep.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals older than 60 years old being sought for enrollment in this study?
"To be eligible for participation, individuals must be between 21 and 70 years old according to the entry criteria of this research."
What is the upper limit on the number of participants involved in this clinical investigation?
"Indeed, the details on clinicaltrials.gov affirm that recruitment is ongoing for this particular trial. The trial was publicly listed on January 1st, 2024 and underwent its latest update on February 22nd of the same year. Participation opportunities are available for a total of 18 individuals at a single designated site."
Who meets the criteria to participate in this medical study?
"Individuals eligible for this trial must be diagnosed with obstructive sleep apnea and fall within the age range of 21 to 70. A total of 18 participants are sought for inclusion in the study."
Are individuals still eligible to apply for participation in this ongoing trial?
"Per information from clinicaltrials.gov, this research trial is presently enrolling participants. The study was originally listed on 1st January 2024 and last revised on 22nd February 2024."
Share this study with friends
Copy Link
Messenger